CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Rheumatoid arthritis - Management
What drug treatments may be offered in secondary care for rheumatoid arthritis?
- Specialists will usually start a combination of disease-modifying anti-rheumatic drugs (DMARDs), plus a short-term corticosteroid.
- Ideally, treatment should be started within 3 months of the onset of symptoms.
- First-line treatment is usually methotrexate and at least one other DMARD.
- For more information, see the CKS topic on DMARDs.
© NHS Institute for Innovation and Improvement